Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 1.902180625
Author: Trendlyne DVM scores

Expensive Rocket

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

80.30 -1.24 (-1.52%)

New 52W High in past week

2.7M

XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Positive Trial

Ions Pharma reports positive results for Phase 3 clinical trial for hepatitis B drug, Bepirovirsen See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

7.7 / 100

Technically Moderately Bullish

66.7 / 100

Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM

1Yr Price target upside is 13%

22 analysts

Ionis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

New 52W High in past week

SWOT Analysis

Ionis Pharma Inc Live Price Chart